CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that David S. Barlow, Chairman and Chief Executive Officer of Molecular Insight Pharmaceuticals, will present at the upcoming UBS Global Life Sciences Conference on Wednesday, September 24, 2008. During his presentation, Mr. Barlow will provide an overview of the Company and its pipeline of molecular imaging radiopharmaceutical and targeted molecular radiotherapeutic candidates. The presentation will take place at 12:00 p.m. Eastern Time in Ballroom D, Carnegie Hall, of the Grand Hyatt New York hotel in New York, New York.
